Alphabet Inc. (GOOGL) subsidiary Google has been facing flak for quite a while now on its plans to launch a censored search engine in China. The project has been criticized by both the company’s employees as well as external groups who claim that it goes against Google’s core values.
Thousands of Google employees were said to have signed a letter raising concerns against the project and have also demanding better clarity from the company to facilitate more ethical decision-making with regards to their work.
Google CEO Sundar Pichai, along with other executives, had a meeting with employees on Thursday during which, questions regarding the China issue were addressed. The CEO tried to assuage the apprehensions of the employees by stating that Google was not in any hurry to launch a search engine in China and that the company was merely exploring the options available in front of it.
Google CEO Sundar Pichai said Google was in no hurry to launch a search engine in China and is merely exploring available options
Pichai added that there was no sufficient clarity with regards to the possibility of a successful launch in the country. However, there is still a lot of uncertainty regarding Google’s China plans and not much was revealed at the meeting.
Several reports have come out on Google’s Chinese search engine. It was claimed that Google was planning to launch a censored version of its search product in China, complying with the country’s strict laws. It was also said that Google, which has always supported an open and free internet, was ready to bend its rules for China, a lucrative market with a large customer base. The company started to get a lot of criticism, including from its own employees.
This is not the first time Google employees have protested its projects on ethical grounds. Earlier in the year, employees came out in protest of Google’s collaboration with the Pentagon over a drone project named Project Maven.
Related: Google’s Chinese search engine plans continue to ruffle feathers
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
